Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

In memoriam: Paul J. Bédard, MD PhD: January 19, 1942-December 26, 2014.

Blanchet PJ, Pourcher E.

Mov Disord. 2015 Mar;30(3):299-300. doi: 10.1002/mds.26186. Epub 2015 Feb 20. No abstract available.

PMID:
25702916
2.

Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.

Smith KM, Eyal E, Weintraub D; ADAGIO Investigators.

JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472.

PMID:
25420207
3.

Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa.

Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H; Droxidopa 302 Investigators.

Hypertension. 2015 Jan;65(1):101-7. doi: 10.1161/HYPERTENSIONAHA.114.04035. Epub 2014 Oct 27.

4.

Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.

Hauser RA, Olanow CW, Kieburtz KD, Pourcher E, Docu-Axelerad A, Lew M, Kozyolkin O, Neale A, Resburg C, Meya U, Kenney C, Bandak S.

Lancet Neurol. 2014 Aug;13(8):767-76. doi: 10.1016/S1474-4422(14)70148-6. Epub 2014 Jul 6.

PMID:
25008546
5.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

PMID:
24664227
6.

Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study.

Emre M, Poewe W, De Deyn PP, Barone P, Kulisevsky J, Pourcher E, van Laar T, Storch A, Micheli F, Burn D, Durif F, Pahwa R, Callegari F, Tenenbaum N, Strohmaier C.

Clin Neuropharmacol. 2014 Jan-Feb;37(1):9-16. doi: 10.1097/WNF.0000000000000010.

PMID:
24434526
7.

Dopaminergic innervation of the human subventricular zone: a comparison between Huntington's chorea and Parkinson's disease.

Parent M, Bédard C, Pourcher E.

Am J Neurodegener Dis. 2013 Sep 18;2(3):221-7. eCollection 2013.

8.

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease.

Pahwa R, Lyons KE, Hauser RA, Fahn S, Jankovic J, Pourcher E, Hsu A, O'Connell M, Kell S, Gupta S; APEX-PD Investigators.

Parkinsonism Relat Disord. 2014 Feb;20(2):142-8. doi: 10.1016/j.parkreldis.2013.08.017. Epub 2013 Sep 5.

9.

Effects of 24 wk of treadmill training on gait performance in Parkinson's disease.

Nadeau A, Pourcher E, Corbeil P.

Med Sci Sports Exerc. 2014 Apr;46(4):645-55. doi: 10.1249/MSS.0000000000000144.

PMID:
24002341
10.

Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.

Factor SA, Wolski K, Togasaki DM, Huyck S, Cantillon M, Ho TW, Hauser RA, Pourcher E.

Mov Disord. 2013 Jun;28(6):817-20. doi: 10.1002/mds.25395. Epub 2013 Apr 15.

PMID:
23589371
11.

Investigation of C9orf72 repeat expansions in Parkinson's disease.

Daoud H, Noreau A, Rochefort D, Paquin-Lanthier G, Gauthier MT, Provencher P, Pourcher E, Dupré N, Chouinard S, Jodoin N, Soland V, Fon EA, Dion PA, Rouleau GA.

Neurobiol Aging. 2013 Jun;34(6):1710.e7-9. doi: 10.1016/j.neurobiolaging.2012.11.025. Epub 2012 Dec 27.

PMID:
23273600
12.

Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.

Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, Pourcher E, Gray J, Thomas G, Swartz J, Hsu T, Moline ML.

Mov Disord. 2012 Sep 1;27(10):1230-8. doi: 10.1002/mds.25098. Epub 2012 Aug 22.

PMID:
22915447
13.

Influence of risperidone on balance control in young healthy individuals.

Corbeil P, Rodrigue J, Simoneau M, Cohen H, Pourcher E.

Psychopharmacology (Berl). 2012 Jul;222(1):59-69. doi: 10.1007/s00213-011-2623-7. Epub 2012 Jan 11.

PMID:
22234381
14.

Istradefylline for Parkinson's disease patients experiencing motor fluctuations: results of the KW-6002-US-018 study.

Pourcher E, Fernandez HH, Stacy M, Mori A, Ballerini R, Chaikin P.

Parkinsonism Relat Disord. 2012 Feb;18(2):178-84. doi: 10.1016/j.parkreldis.2011.09.023. Epub 2011 Oct 13.

PMID:
22000279
15.

Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.

Bédard C, Wallman MJ, Pourcher E, Gould PV, Parent A, Parent M.

Parkinsonism Relat Disord. 2011 Sep;17(8):593-8. doi: 10.1016/j.parkreldis.2011.05.012. Epub 2011 Jun 12.

PMID:
21664855
16.

Balance control improves following replacement of paroxetine with venlafaxine and levodopa in a case of microvascular dementia.

McDonald J, Corbeil P, Pourcher E.

Am J Geriatr Pharmacother. 2011 Apr;9(2):133-7. doi: 10.1016/j.amjopharm.2011.03.002. Epub 2011 Apr 19.

PMID:
21507731
17.

Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial.

Hauser RA, Cantillon M, Pourcher E, Micheli F, Mok V, Onofrj M, Huyck S, Wolski K.

Lancet Neurol. 2011 Mar;10(3):221-9. doi: 10.1016/S1474-4422(11)70012-6.

PMID:
21315654
18.

Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study.

Frölich L, Ashwood T, Nilsson J, Eckerwall G; Sirocco Investigators.

J Alzheimers Dis. 2011;24(2):363-74. doi: 10.3233/JAD-2011-101554.

PMID:
21258153
19.

Intense dopamine innervation of the subventricular zone in Huntington's disease.

Bédard C, Wallman MJ, Pourcher E, Parent A, Parent M.

Neuroreport. 2010 Dec 8;21(17):1074-9. doi: 10.1097/WNR.0b013e32834052a6.

PMID:
20926973
20.

Emotion and object processing in Parkinson's disease.

Cohen H, Gagné MH, Hess U, Pourcher E.

Brain Cogn. 2010 Apr;72(3):457-63. doi: 10.1016/j.bandc.2010.01.001. Epub 2010 Feb 18.

PMID:
20167412
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk